This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Cancer Alliance To Serve Patients Across The Region

SPOKANE, Wash., May 7, 2013 /PRNewswire-USNewswire/ -- Cancer Care Northwest, Kootenai Health and Providence Health Care – the region's premier health care leaders in cancer services – have signed a Memorandum of Understanding to form a new regional cancer alliance aimed at elevating the quality, coordination and care experience for patients and their families throughout the inland northwest.  This is not a merger or acquisition. It is an innovative model of clinical collaboration between three committed cancer care providers.  

(Logo: )

(Logo: )

(Logo: )

"Our goal is to build regional centers of excellence in oncology that will continually provide our patients with the latest advances in cancer therapies, cutting-edge research and the most sophisticated technology," says Warren Benincosa, chief executive officer of Cancer Care Northwest (CCNW). "By combining the expertise of each organization, our aim is to further expand the coordinated treatment of cancer patients, allowing them to remain close to home for their care."

The new alliance is the first step in creating an environment that will make local advancements in cancer care possible.  These potentially include adoption of evidence-based clinical protocols, medical research and clinical trial opportunities that bring additional treatment options to patients, improved physician recruitment, community education and prevention programs, expansion of tumor conferences that use multidisciplinary teams of experts to evaluate patients' cancers to determine the best course of treatment, and expansion of programs and services like patient navigators that assist patients through the cancer treatment process.

The new alliance's first endeavor is to create a comprehensive and integrated radiation treatment program to serve patients throughout the region. The intent is to develop one coordinated radiation oncology program across the three organizations creating greater efficiencies and improved access to advanced, targeted radiation tools that enhance treatment response and minimize side effects.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs